Expression Competent Cells Market

The Protein Expression Competent Cell Pack lets you efficiently economically optimize expression by simultaneously testing multiple strains with your gene of interest. The pack includes BL21(DE3) competent cells for nontoxic proteins and BL21(DE3) pLysS competent cells for both toxic and nontoxic proteins.
Expression Competent Cells Market contains market size and forecasts of Expression Competent Cells in Global, including the following market information:
Global Expression Competent Cells Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Expression Competent Cells market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Chemically Competent Cells Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Expression Competent Cells include Merck KGaA, Thermo Fisher Scientific, Agilent Technologies, Takara Bio, Promega Corporation, Beijing TransGen Biotech, GeneScript Corporation, Yeastern Biotech and New England Biolabs, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Expression Competent Cells companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Expression Competent Cells Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Expression Competent Cells Market Segment Percentages, by Type, 2021 (%)
Chemically Competent Cells
Electrocompetent Cells
Global Expression Competent Cells Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Expression Competent Cells Market Segment Percentages, by Application, 2021 (%)
Protein Expression
Other
Global Expression Competent Cells Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Expression Competent Cells Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Expression Competent Cells revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Expression Competent Cells revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck KGaA
Thermo Fisher Scientific
Agilent Technologies
Takara Bio
Promega Corporation
Beijing TransGen Biotech
GeneScript Corporation
Yeastern Biotech
New England Biolabs
QIAGEN N.V.
OriGene Technologies
Lucigen
Zymo Research
Bio-Rad Laboratories
Bioline
Delphi Genetics
IBA GmBH
Cell Applications
BioDynamics Laboratory
Scarab Genomics